Please login to the form below

Alzheimer's Society

This page shows the latest Alzheimer's Society news and features for those working in and with pharma, biotech and healthcare.

Biogen defends aducanumab filing plan amid scepticism

A new look at pivotal trial data described as hard-to-interpret. A much-anticipated presentation of data from Biogen’s pivotal trials programme for Alzheimer’s disease candidate aducanumab has ... Dr James Pickett, head of research at Alzheimer’s

Latest news

Online therapy for dementia carers to be studied

The project is being co-led by the Oxford Health NHS Foundation Trust and the Alzheimer’s Society and they’ll assess an online programme called ‘ Caring for Me and You’. ... Dr Doug Brown, director of research and development at the Alzheimer’s
Researchers say 'neurostatins' may ward off Alzheimer's

in a model of Alzheimer's disease (AD) by preventing the production of neurotoxic beta-amyloid aggregates. ... A note of caution has been sounded by Doug Brown, R&D director at the Alzheimer's Society, who noted that Bexarotene has many side effects
Glimmer of hope for amyloid drugs in Alzheimer's?

Clinical trials have provided some preliminary evidence that drugs targeting amyloid may help delay Alzheimer's disease (AD), although scientists stress it is far too early to draw conclusions. ... The trial still has another two years to run. The
Charity coalition pledges millions for brain disease research

The funding will focus on neurodegenerative conditions, such as dementia, motor neurone disease and Parkinson's disease for which there is an unmet need. ... Neuro–MAP's partners are Alzheimer's Association US, Alzheimer Research UK, Alzheimer's
Boehringer gets ‘kite mark’ for health information

Organisations signed up to the TIS include charities, such as the Alzheimer's Society and the British Liver trust, private healthcare provider Bupa and many NHS trusts, but Boehringer is the ... And to do so, it's vital that all parties have the right

More from news
Approximately 1 fully matching, plus 29 partially matching documents found.

Latest Intelligence

What can pharma learn from the charity sector?

Georgina Carr, Head of External Relations and Campaigns at the MS Society, works with people with MS on a daily basis: “Co-creation has been key in the health charity sector ... Dr Doug Brown, Chief Policy and Research Officer at Alzheimer’s Society,
Holding on to hope for Alzheimer’s advances

750 people with prodromal to mild Alzheimer’s; that too is scheduled to complete in 2020. ... The project is a joint £250m investment into dementia research led by the Medical Research Council, alongside the Alzheimer’s Society and Alzheimer’s
Boehringer Ingelheim on walking the talk in patient-centricity

The role is the first position at the company that Dugi has taken outside Boehringer's homeland. ... In signing up to The Information Standard, Boehringer joins the likes of the Alzheimer's Society and the British Liver Trust, private healthcare provider

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

UK Dementia Research Institute names director

In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics
NHiS appoints mental health associate director

During this time, he has worked closely with local authorities to publish the Merton Mental Health Needs Assessment and helped to develop the Alzheimer's Society's Dementia Hub. ... capability. “Following Laurence's appointment, we can now offer

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Havas Lynx pushes the boundaries of creative healthcare with new recruits

Lou’s varied portfolio includes powerful and compelling campaigns for Cancer Research UK, Save the Children and Alzheimer’s Society. ... It’s great to see so many high profile and brilliant creatives recognise this and join our mission.
Attigo (part of the Mednet Group)

Alzheimer’s Research UK. Alzheimer’s Society. Basic Needs. Biogen. Butterfly Scheme. Cardiomyopathy UK. ... Communique - Winner:Innovation . PM Society - Winner: Digital Media. 0113 386 4415.
Alzheimer's and Brain Awareness Month

3. Alzheimer’s Society website. Available at Last accessed June 2017. 4. ... 5. Alzheimer's hopes dashed as Lilly gives up on amyloid drug solanezumab.
emotive choose a charity to support in 2016

A total of 24 charities were put forward and vigorously defended, including Crisis, Alzheimer’s Society, Stroke Association, War Child, Orangutan Foundation, Age UK, Solar Aid, and Battersea Dogs and Cats ... Adam Boucher, emotive’s Client Services

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Account Director or Senior Account Director: Salary TBC

Account Manager– Medical Communications: (Negotiable - depending on experience)

Vice President: Competitive Salary Offered

Consultant: competitive salary

Senior Medical Writer, MedComms Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

How do companies prepare for reimbursement?: Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
Integrating electronic health records into clinical trials: How organisations are working to realise the research potential of EHRs...
Keeping up the fight against HIV and using the lessons to tackle other threats: Danny Buckland interviews Gilead’s Mike Elliott...